EMAIL THIS PAGE TO A FRIEND

Annals of the rheumatic diseases

Changing sulphasalazine to methotrexate does not improve the 2-year outcomes of the initial single DMARD treatment in early rheumatoid arthritis: subanalysis of the FIN-RACo trial.


PMID 23349132

Abstract

We're sorry this abstract is currently not available.